Abstract: A gastroenterologist's practice in a Boston metropolitan academic community hospital was reviewed for all cases of parasitic disease seen in that practice as part of routine GI referral patterns from October 10, 2009 to September 9, 2013. The practice did not specialize in the treatment of parasitic diseases. 104 patients were identified and evaluated for their methods of diagnosis, treatment, laboratory values and types of parasites. Serological results for all testing done by health care providers at the Cambridge Health Alliance (CHA) for Strongyloides stercoralis and Schistosomiasis (all species) were then reviewed for two one year periods. The study patients had parasitic infections that reflected the infestations endemic in their countries of origin. Language was used as a surrogate for the patient's country of origin. The methods used for the diagnosis of parasitic infections included serologic studies (98/104: 94.2%), pathological examination of biopsy specimens with serology (19/104: 18.3%), pathological examination alone (6/104: 5.8%) and fecal ova and parasite testing (O&P) (2/104: 1.9%). 93/104 (89.4%) of the patients had a positive serology for Schistosomiasis, Strongyloides or both. None of the Schistosomiasis or Strongyloides patients were detected or confirmed with O&P studies (0/103: 0.0%). Several neoplastic lesions of the gut were noted (16/104: 15.4%), of which 3 (3/104: 2.9%) were adenocarcinomas of the colon. Tissue biopsy is a specific test. Schistosomiasis and Strongyloides serology are sensitive tests. Given the short time needed to treat these infections, and the relatively safe side effect profile for these therapies, the use of antibody and pathological testing with treatment of positive results seems to be a reasonable approach. Evaluation for parasites in asymptomatic, newly arrived immigrants and individuals with a distant history of immigration or travel to areas at risk (especially patients with eosinophilia) should be done as part of their routine health care. Transplant donors originally from endemic areas should have serological examination for Strongyloides stercoralis and Schistosoma species prior to organ transplant or fecal microbiota transplantation (FMT). All patients at risk for these infections should be diagnosed and treated prior to immunosuppressive therapy. This is especially true for patients with Strongyloides, given the unacceptable high mortality rate of hyperinfection syndrome. Such a strategy may prevent the consequences of chronic parasitic infestations and limit a potential public health hazard.
INTRODUCTION
In this case review series, we present 104 patients seen in a single general clinical gastroenterologist practice between October 28, 2009 and September 9, 2013 who were found to have evidence of parasitic diseases. The patients were initially referred to a single general clinical gastroenterologist practice for routine gastrointestinal complaints at the Cambridge Health Alliance (CHA), an academic community based hospital system in Cambridge, Somerville and Everett Massachusetts ( Table 1 ). CHA's patient population is racially and ethnically diverse with over 40% speaking a language other than English. Each year, CHA serves more than 400,000 residents of Boston's Metro North region in its ED, hospital and ambulatory settings, placing special emphasis on preventive care and in serving the area's most vulnerable and diverse populations [1] .
*Address correspondence to this author at the Cambridge Health Alliance, Somerville Hospital, 230 Highland Ave, Somerville, MA 02143, USA; Tel: 617-591-4760; Fax 617-591-4041; e-mail mpayne@challiance.org All patients in the practice with a parasitic illness of any kind during that interval were included in this report.
The methods of diagnosis, treatment, laboratory values and types of parasites in this case review provide an interesting perspective of the pervasiveness of parasitic diseases in our community.
We also reviewed the results for all serological tests for Strongyloides stercoralis and Schistosoma (all species) done by physicians at the Cambridge Health Alliance for two one-year periods.
METHODS
Patients with endoscopic, pathologic, radiographic, serologic or stool ova and parasite evidence of a parasitic infection seen from October 28, 2009 through September 9, 2013 in a single gastroenterologists practice were categorized by age, sex, primary language (as a surrogate for their country of origin), method of diagnosis, results of stool ova and parasite testing, type of parasite, eosinophil count, hematocrit and co-morbidities (such as cancer or inflammatory bowel disease).
Pathology specimens (enteric and colonic biopsies) were fixed in 10% formalin and processed in the usual manner for histological examination. All tissue sections were cut at four microns stained with hematoxylin and eosin stain and examined using light microscopy. Parasites were identified microscopically by their unique morphologic characteristics.
From April 2011 to May 2013, serological tests were performed by the Laboratory Corporation of America. After May of 2013, all serological testing was done at Cambridge Hospital clinical laboratory. Strongyloides antibodies were detected by use of enzyme-linked immunosorbent assays (ELISA) on microtitration wells sensitized with Strongyloides ratti somatic larval antigens. The presence of an IgG antibody in the serum was detected with a protein A-alkaline phosphatase conjugate. Schistosomal antibodies were detected in a patient's serum using a qualitative immunoenzymatic reaction with determination of IgGclass antibodies against Schistosoma mansoni based on the ELISA (Enzyme-linked Immunosorbent Assay) technique. Borderline positive results were treated as positive results and treated. For the purpose of this study, positive results were defined as true positives or equivocal positives as defined by the assay being used ( Table 3) Stool examination for ova and parasites (O&P) included a gross examination, a wet mount (if submitted fresh), and a permanently stained smear using a Trichrome stain. Stools were also examined grossly for the presence of worms, by microscopic wet mount for trophozoites, and by Trichrome stained slides for eggs. Any parasites were identified by their size (determined by ocular micrometer) and their unique morphologic characteristics. Screening for strongyloidiasis involves serologic testing or stool culture. Stool ova and parasite examination may be used, but testing of three samples results in less than 60% sensitivity and up to 7 samples may be necessary to increase sensitivity to more than 90%. Serologic testing is the most sensitive test for screening schistosomiasis, it is widely available and positive results are sufficient to confirm the diagnosis. A combination of more than one testing technique may increase sensitivity and specificity [2, 3] . Stool ova and parasite testing may detect infection, although, similar to testing for strongyloidiasis, sensitivity can be quite low. Diagnosis of schistosomiasis can be made using stool, urine studies, or serologies. 
RESULTS
73 of the patients were males (mean age of 49.3 yrs) and 31 were females (mean age of 49.7) yrs. (Table 1b) . Many of our patients originally came from other countries where pathogenic parasites are endemic. Our population's diversity is reflected in the languages of our patients. Therefore, language was used as a surrogate marker for place of origin since that information was not always reliably available.
In the GI division, 51% of all patients seen in 2012 were English speaking, 13% were Spanish speaking, 19% were Portuguese speaking (the great majority of them being Brazilian), 7% were Haitian Creole and 10% spoke other languages [4] . In our study population, however, 47.1% of the study patients were Brazilian/Portuguese speaking. Of these patients 69.4% had Schistosomiasis, 16.3% and had Strongyloides. English speakers made up the next largest group (11.5%), of which 91.7% had Schistosomiasis and 8.3% had Strongyloides. Of note, some patients who had come from Brazil and Latin America identified themselves as English speakers (Table 3) . However, O&P is still useful for other pathogens.
Only four of the patients seen in this series (3.8%) were known prior to their first encounter to have a parasitic illness. The rest were patients referred for routine GI consultations and for screening colonoscopies. 96.2% of the patients were diagnosed as having a parasitic infection as part of their work up for another problem. A pathologic examination of biopsies provides a high degree of certainty for diagnosis, but limited sampling may decrease the sensitivity of this method. In our study 38/104 (36.5%) of patients were diagnosed on the basis of pathological findings although only 6/104 (5.80 %) were diagnosed on pathology alone. 98/104 (94.2%) had a serological diagnosis made. Video capsule endoscopy also proved useful in diagnosing 3/104 (2.9%). Another patient was diagnosed visually to have taenia saginata during a colonoscopy. Three patients (2.9 %) were found to have adenocarcinoma of the colon, 1 was found to have a carcinoid of the rectum and one had an adenocarcinoma of the stomach. Of the colon adenocarcinomas, two were diagnosed as having 68/104 (65.4%) of the patients in our study had evidence of Schistosomiasis, 40/104 (38.5%) Strongyloides and 10/104 (9.6%) had another type of parasite. None of the patients in this study could recall prior therapy for their infections within the past 3 years.
Some papers [2, 5] have argued that in immigrant patient populations, the finding of eosinophilia on a peripheral blood smear should initiate an aggressive work up for pathogenic parasites. In our study only 90/104 (86.5%) of the patients had eosinophil counts done. Of these patients, 19/90 (21.1%) exhibited eosinophilia (defined as an eosinophil percentage of 7% or higher).
DISCUSSION
The American Society of Tropical Medicine and Hygiene (ASTMH), founded in 1903, used the term "tropical disease" to refer to illness unique to that region of the earth lying between the Tropic of Cancer and the Tropic of Capricorn [6] . It was generally assumed that in the tropics, warm climate, poverty, lack of education and poor sanitation provide an ideal environment for pathogens, vectors and intermediate hosts to flourish [7] . This definition suggested that tropical infections would be rare in the "temperate climate" of the United States and Europe. Because of this assumption and the social complexities of immigration and international travel in the 21 st century, many patients who have been exposed to parasitic infections are never effectively tested. There are relatively few physicians in the United States who do not encounter problems in the area of tropical medicine with surprising regularity [3, 8] . [10] . Chronic symptoms caused by these pathogens may be attributed to other etiologies, often diseases that require immunosuppressive therapy, such as asthma or inflammatory bowel disease. Finally, when Schistosomiasis or Strongyloides infections are a concern, ova and parasite testing is usually ordered to evaluate this possibility.
The Center for Disease Control has issued guidelines for the screening of newly arrived asymptomatic adults with stool ova and parasites x 2, serologies for Strongyloides and Schistosomiasis, and CBC with differentials. Available treatments for both Strongyloides and Schistosomiasis are safe and require no more than one to two days of therapy, although treatment for Strongyloides should be done after evaluation for Loa loa if the patient is from an area at risk for this parasite (Sub Saharan Africa) [2, 3] . Our study supports that this screening effort is warranted in recently immigrated patients [2, 5, 11, 12] . It also suggests that individuals who immigrated to the U.S. decades ago and natural born citizens who have visited endemic areas may also need to be vigorously evaluated.
Strongyloides stercoralis is a Nematode, a organism that is 2 mm long which conservatively infects an estimated 30 to 100 million people worldwide [10] . Symptoms include abdominal pain (most commonly in the midepigastrum), nausea, vomiting, diarrhea, anorexia, weight loss, weakness and generalized urticaria. Clinical exacerbations recur at irregular intervals and may be due to cycles of hyerinfection. Wheezing and asthma like symptoms have been reported in 10% of infected patients. Eosinophilia may be seen but is not always present [5] . Ova and parasite studies are relatively insensitive for this pathogen [11] . Since effective therapy has been available only since 1967, many persons (e.g., military personnel who were in the South Pacific in World War II, the Korean War, or the Vietnam War) may remain infected and at risk [10] . A chronic, persisting infection can present in a classic triad of abdominal pain, diarrhea, and larva currens (a form of pruritic dermatitis). This presentation has been seen in the United States in Southeastern Kentucky and elsewhere in Appalachia, where Strongyloides is an endemic problem. Patients from this area are usually white, male, 50 years of age or older, and from lower socioeconomic backgrounds, but without travel histories to areas outside of the United States [10, 13] .
Strongyloides can cause an especially lethal infection in patients who are immunocompromised. Patients who are on immunosuppressive agents such as steroids and transplant medications are at risk. Patients with hematological malignancies (especially lymphoma), TB, malnutrition (especially due to chronic Strongyloides diarrhea) or patients with HIV are also at significant risk [10, [14] [15] [16] [17] . In such individuals, a massive form of hyperinfection with severe disseminated disease may occur. This is in part due to the parasites increased reproduction and migration at the "removal" of the immune systems inhibition [18, 19] . Respiratory failure, gram negative sepsis and death are not uncommon in corticosteroid treated patients. Case fatality rates as high as 87% have been reported [14, 20] .
Treatment for Strongyloides with Ivermectin may be potentially lifesaving in patients who require therapy with immunosuppressive agents, although care must be taken to exclude a Loa loa parasitic infection in patients from sub Saharan Africa [3] . Optimal therapy usually requires a very short duration of treatment, usually no more than two doses of medication given a day or more apart. Until recently Ivermectin was the primary medication in the United States for Heartworm prevention in dogs. The American health care community has therefore had a great deal of experience using this drug… in our pets [21, 22] .
The other major parasite seen in this study is Schistosomiasis, a disease caused by several members of the Phylum Platyhelminthes. According to the World Health Organization, at least 243 million people worldwide required treatment in 2011, although only about one tenth of this number was actually treated [23] . Schistosomiasis has been called one of the most important neglected tropical diseases (NTDs) [24] . It is a chronic illness that can damage internal organs and, in children, impair growth and cognitive development. It is the second most socioeconomically devastating parasitic disease in the world after malaria [25] . Each year, over 280,000 patients die because of the disease, and increasing numbers of tourists are contracting Schistosomiasis. They usually present when they return to their home countries with severe acute infections and unusual problems including paralysis [23, 26, 27] . Even a history of brief water exposures in an endemic area or an unexplained eosinophilia in a returning tourist may suggest active Schistosomiasis. In such cases, the serology may not acutely turn positive and further evaluation over time may be necessary [27] .
There are five species of Schistosoma that develop to maturity in humans. Once exposed to a human host, cercariae enter through the skin, causing mild pruritus and papular dermatitis, usually at their point of entry. They then proceed as schistosomula, where they reach the venous circulation en route to the lungs. They then perforate pulmonary capillaries and the alveolar capillary barrier and go up the bronchial tree into the pharynx, where they are swallowed. The parasites then reach the gut, where they migrate to the portal venous system. At this point, males and females mature and mate. The united pair of worms then migrates upstream to the superior mesenteric veins or the inferior mesenteric veins and superior hemorrhoidal veins or vesical plexus, where they penetrate through the blood vessel walls into adjacent tissue and reach the small intestine, colon, or bladder mucosa. At this point, they produce eggs, which can be shed in the feces (S. mansoni and S. japonicum) or the urine (S. haematobium) [8, 9] . Therefore, via hematological or lymphatic spread, this parasite can reach the lungs, liver colon, small bowel, bladder and CNS and produce local disease [8, 9, 28] .
The chronic disorders seen in Schistosomiasis are predominately due to a T helper cell type 2 immune response targeted against schistosomal eggs. About one-third of the schistosomal eggs do not go down the intestinal lumen but rather are deposited in the small veins of the liver due to portal flow [26] . The TH2 granulomatous response is responsible for the presinusoidal cirrhosis of the liver, which is observed in this condition. This causes portal hypertension without hepatic failure since the hepatocytes are not significantly damaged unlike most causes of portal hypertension.
The portal hypertension in Schistosomiasis can still lead to esophageal and gastric varices and splenomegaly. Schistosomiasis also leads to hepatomegaly, inflammatory colonic polyps (see Figures 1 and 2) , hematochezia and anemia. The worm burden in the intestine is not inconsequential. Jejunal perforation due to adult worms has been reported [29] . The urinary system is also a target. Cystitis, urethritis, glomerulonephritis and bladder cancer can occur due to chronic infections. Pulmonary hypertension, with subsequent right heart failure can also occur due to mechanical impaction of eggs in the pulmonary vasculature, the inflammatory process they induce and higher blood flow as a result of significant AV shunting caused by portal hypertension [26] . Other sequela of egg migrationinduced TH2 response include CNS lesions such as cerebral granulomatous disease and transverse myelitis. Immunosuppression due to therapy after transplantation or associated with conditions such as HIV infection, increases susceptibility to various central nervous system infections [28] .
Praziquantel is the preferred treatment for Schistosomiasis at this time. It is the medicinal basis of most global efforts to decrease the impact of Schistosomiasis throughout the world [30] .
In our study, Strongyloides was found or suggested in 38.5% of the study population and Schistosomiasis in 65.4% of these patients. These two organisms were by far the most common positive tests seen, and this observation raises a significant concern about the long term health of our larger population.
Water and soil containing parasitic, bacterial or viral pathogens may also contain Strongyloides or Schistosomiasis. At risk individuals presenting with any parasitic disease should therefore be tested for these pathogens as well. In this study 8 patients were found to have parasites other than Schistosomiasis and Strongyloides. 3 of these 8 patients were found to have positive serologies for Strongyloides or Schistosomiasis: Trichuris (one for Schistosomiasis), Taenia (one for Schistosomiasis) and Trypanasoma (one for strongyloides).
Moreover patients may show serological evidence of more than one infection [12] . Although it has been suggested that this may be due to a cross reactivity of different serological tests, simultaneous infestation could also be an explanation. In this study 10 patients (9.6 %) had serology positive for both Strongyloides and Schistosomiasis. 16/104 patients (15.4%) had had evidence of more than one parasitic infection. In those cases, both parasites were treated (at different times) as a way of making sure there neither infection was missed. Should a patient have a positive parasitic antibody test for either Strongyloides or Schistosomiasis, further testing for the other infection should also be considered. Since 82/104 (78.8%) of those with a positive antibody test for one organism did not show positivity for the other, the question of cross-reactivity may not be a major issue.
Although ova and parasite examinations are extensively used, they are known to be laborious and technically demanding. An every other day collection of stool x3 is optimal for this test but difficult to achieve. None of the patients in this study were initially diagnosed or treated for Strongyloides or Schistosomiasis due to a positive O&P result for these organisms. Two patients had a set of O&P's that were positive for other parasites, however in one patient this lead to serological testing that was positive for Schistosomiasis. Other parasites may therefore serve as a surrogate marker for Schistosomiasis and Strongyloides. Even when properly done, the O&P is far from reliable. One patient in this series was diagnosed by colonoscopy to have visible Taenia saginata and had a negative O&P done on stool obtained at the time of colonoscopy. Our findings confirm that a negative ova and parasite stool test does not appear to be a gold standard for the presence or absence of Strongyloides and Schistosomiasis [11] .
Of interest, one patient in this study with a Strongyloides infection developed symptoms and rising antibody titers after having a good antibody response to treatment years before. They reported that they had returned to their native country for a visit after therapy and may have been re-exposed to the pathogen. Unlike Schistosomiasis antibody titers, Strongyloides serologies can be used to follow patients who have been treated. There is no evidence to suggest that treatment infers a lifelong immunity to these two pathogens. Both Schistosomiasis and Strongyloides can be contracted more than once after effective therapy. Most Schistosomiasis eradication programs will retreat the people of an endemic area on an annual basis [25] . Schistosomiasis may therefore be reacquired by re-exposure to a contaminated water source. Likewise, a visit to an endemic area or an exposure to an infected person living in the same household may be enough to re-infect a previously treated patient with Strongyloides. Individuals living in intimate contact with such a patient that has Strongyloides should be checked and treated at the same time. Given the risk of hyperinfection syndrome, even equivocal tests for Strongyloides were treated as positives. The one patient with equivocal results for Schistosomiasis had biopsy proof of the organism.
Three of the patients in our study (2.88 %) were found to have adenocarcinoma of the colon. Two (1.92%) were diagnosed as having Schistosomiasis (both pathologically and one serologically) and one was diagnosed as having Strongyloides (by serology). One patient had a carcinoid of the rectum and one had an adenocarcinoma of the stomach. There were 11 noncancerous neoplastic polyps seen in the Schistosomiasis and Strongyloides groups. Overall, 16 (15.4%) of the cases had significant neoplasia in the colon. Although bladder cancer has been well described as a complication of Schistosomiasis, no correlation has been made with colorectal cancer. There is no known correlation of Strongyloides to colon cancer either. Both pathogens however can cause chronic inflammation in the colon that may last for decades. A potential association between GI cancers and these two organisms should be considered for future investigation.
Nineteen of the ninety patients who had eosinophil counts obtained (21.1%) exhibited eosinophilia on their peripheral smear. Eosinophilia may be helpful in selecting patients to be tested for Schistosomiasis or Strongyloides, but it is by no means a definitive indicator.
Using pathology and serology together may be the best means of making a diagnosis. Serological testing tends to have a high sensitivity, but very low specificity given the risk of false positive results in patients who have been treated in the past. Pathologic examination of biopsies provides a high degree of specificity, but has low sensitivity given the problem of sampling error.
If biopsies taken during endoscopic procedures are suggestive of a parasitic infection but identification of the parasite cannot be made, serologies should be checked for Strongyloides and Schistosomiasis, and treatment based upon the results.
The prevalence of parasites found as part of routine screening colonoscopies would be another area worthy of future examination. Most of the endoscopic studies done were done as screening colonoscopies. Screening colonoscopy for colorectal cancer may prove useful in at risk populations. If the colonoscopist is aware that a patient is at increased risk for parasitic infections, targeted biopsies during the procedure might increase diagnostic yield.
Other studies have shown duodenal biopsies to be most accurate in diagnosing Strongyloidiasis [32] . Biopsies taken of the duodenum in high risk individuals (symptomatic, immunosuppressed and with a travel history to an endemic area) might be a worthwhile strategy for diagnosis.
Because of their need for long term immunosuppressants, transplant patients are at significant risk from Strongyloides and Schistosomiasis. Donors for all forms of solid organ transplants are carefully screened. Fecal microbiota transplantation (FMT) is now being used as a means of treating recurrent Clostridium difficile colitis and has been suggested as a means of treating Inflammatory Bowel Disease [33, 34] . The protocols for screening transplant donors are critical in preventing the spread of unsuspected infections. At present, evaluation for fecal parasitic pathogens is usually done by means of the standard series of ova and parasite tests on potential stool donors [33, 34] . Should a patient receive a transplant from an infected donor (especially in FMT), it is highly likely that a parasitic infection such as Strongyloides could be transferred to the new host. Studies should be done to assess the efficacy of checking donors for Strongyloides stercoralis and Schistosomiasis prior to transplant [15] .
CONCLUSION
Cambridge Health Alliance in Cambridge, MA serves a diverse patient population, many of whom are from countries where pathogenic parasites are endemic.
47.1% of the patients were Brazilian/Portuguese speaking. Of these patients, 69.4 % had Schistosomiasis, 16.3% had Strongyloidiasis and 14.3% had both. In all other language groups (52.9%) combined 41.8% had Schistosomiasis, 43.6% had Strongyloidiasis and 5.6% had both. Further studies need to be done to evaluate prevalence and develop better criteria for screening.
The methods we used for the diagnosis of parasitic infections ( Table 3 ) included serologic studies, pathological examination, endoscopic visualization and stool O&P. The pathological findings in this study (36.5% of all cases) give strong support to the validity of the serological data. 40/104 (38.5%) of the patients had serologies positive or equivocal for Strongyloides and 68/104 (65.4%) had serologies positive or equivocal for Schistosomiasis. Only 5/104 (4.8%) of the patients had another type of parasite and did not have a positive Schistosomiasis or Strongyloides antibody titer. None of the Schistosomiasis or Strongyloides patients were detected or confirmed using stool O&P (0/103: 0.0%). O&P studies may not play an important diagnostic role for these two organisms, although they are still useful for other parasitic infections.
When all serologies at CHA for Schistosomiasis and Strongyloides were reviewed for two one year periods, they showed a 19.0 -21.0% positive rates for Schistosomiasis and 6.5 -8.6% positive rates for Strongyloides. This suggests that the findings of this study were not limited to a single gastroenterologist's practice.
Serologic evaluations for Schistosomiasis and Strongyloides are reliable and helpful screening methodologies. The relationship between serological testing and actual infection needs to be better correlated in future studies, however pathological data suggests that infection rates detected by serology are reasonably accurate. Given the short time needed to treat these infections, and the relatively safe side effect profile for their therapies, the treatment of positive serological results seems to be a reasonable approach [2, 3] . Such a strategy may prevent the consequences of chronic parasitic infestations and limit a potentially large public health hazard.
